Filing Flows › Comparisons › ONC vs OGN
BeOne Medicines vs Organon: ONC and OGN compared
BeOne Medicines is the larger company: $1.9B of revenue in its latest quarter (Q3 2026) against $1.6B for Organon (Q3 2026). BeOne Medicines is growing faster (+34% against -2% a year earlier). BeOne Medicines is more profitable, with an operating margin of 22.2% against 16.2%.
Where the money goes: ONC and OGN
BeOne Medicines (ONC) · Q3 2026
BeOne Medicines, Q3 2026: revenue $1.9B (+34% year over year), operating margin 22.2%, net earnings $385M, operating cash flow $509M. The chart follows the revenue to costs, profit and cash.
Organon (OGN) · Q3 2026
Organon, Q3 2026: revenue $1.6B (-2% year over year), operating margin 16.2%, net earnings $164M, operating cash flow $370M. The chart follows the revenue to costs, profit and cash.
| BeOne Medicines (ONC) | Organon (OGN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.9B | $1.6B |
| Revenue growth, Y/Y | +34% | -2% |
| Gross margin | 88.5% | 55.2% |
| Operating margin | 22.2% | 16.2% |
| Net earnings | $385M | $164M |
| Net margin | 20.4% | 10.4% |
| Operating cash flow | $509M | $370M |
| Free cash flow | $474M | $326M |
| Market value | $624.2B | $3.8B |
| P/E | — | 18.0× |
| Analysts’ mean target | $437.57 | $10.33 |
Where the revenue comes from
BeOne Medicines
- Product revenue, net: $1.9B (98%)
- BAITUOWEI: $22.1M (1%)
- POBEVCY: $10.7M (1%)
Questions
Which is bigger, BeOne Medicines or Organon?
BeOne Medicines is the larger company: $1.9B of revenue in its latest quarter (Q3 2026) against $1.6B for Organon (Q3 2026).
Is BeOne Medicines or Organon growing faster?
BeOne Medicines is growing faster (+34% against -2% a year earlier).
Which is more profitable, BeOne Medicines or Organon?
BeOne Medicines is more profitable, with an operating margin of 22.2% against 16.2%.
More: BeOne Medicines earnings · how BeOne Medicines makes money · Organon earnings · how Organon makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Oct 30, 2026). Fiscal quarters can end on different dates. Not investment advice.